Yu, X., Ghamande, S., Liu, H., Xue, L., Zhao, S., Tan, W., . . . Liu, H. Y. (2018). Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer. Elsevier.
Chicago Style (17th ed.) CitationYu, Xiaolin, et al. Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity Against HER2+ Breast Cancer. Elsevier, 2018.
MLA (8th ed.) CitationYu, Xiaolin, et al. Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity Against HER2+ Breast Cancer. Elsevier, 2018.
Warning: These citations may not always be 100% accurate.